Deutsche Bank Downgrades Argenx SE (ARGX) to Hold From Buy

Argenx SE (NASDAQ:ARGX) is one of the top high growth international stocks to buy right now. On September 11, Deutsche Bank downgraded Argenx SE (NASDAQ:ARGX) to Hold from Buy, keeping the price target unchanged at EUR 655.

The firm noted that the stock price shot up more than 40% since its pre-Q2 upgrade two months ago, stating that it is attempting to be “reasonably disciplined” with its valuation and price target framework.

Headquartered in Amsterdam, the Netherlands, Argenx SE (NASDAQ:ARGX) is a biotech company that develops treatments for severe autoimmune diseases. The company operates through four segments: the United States, Japan, EMEA, and China.

While we acknowledge the potential of ARGX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.